Potential for Increasing Uptake of Radiolabeled 68Ga-DOTATOC and 123I-MIBG in Patients with Midgut Neuroendocrine Tumors Using a Histone Deacetylase Inhibitor Vorinostat-Reference-Cited by-同舟云学术

Potential for Increasing Uptake of Radiolabeled 68Ga-DOTATOC and 123I-MIBG in Patients with Midgut Neuroendocrine Tumors Using a Histone Deacetylase Inhibitor Vorinostat

Published:2021-10-01 Issue:8 Volume:36 Page:632-641
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Pollard Janet H.¹²,Menda Yusuf¹,Zamba K.D.³,Madsen Mark¹,O'Dorisio M. Sue⁴,O'Dorisio Thomas⁵,Bushnell David¹²

Affiliation:

1. Department of Radiology, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.

2. Iowa City Veterans Administration Health Care System, Iowa City, Iowa, USA.

3. Department of Biostatistics, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.

4. Department of Pediatrics, and University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.

5. Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/cbr.2020.4633

Reference22 articles.

1. One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

2. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

3. Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors

4. Phase I Trial of 90Y-DOTATOC Therapy in Children and Young Adults with Refractory Solid Tumors That Express Somatostatin Receptors

5. Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastroenteropancreatic neuroendocrine tumors: Epigenetic landscape and clinical implications;Current Problems in Cancer;2024-10

2. Pancreatic Neuroendocrine Tumors: Signaling Pathways and Epigenetic Regulation;International Journal of Molecular Sciences;2024-01-22

3. Improving susceptibility of neuroendocrine tumors to radionuclide therapies: personalized approaches towards complementary treatments;Theranostics;2024

4. Applying HDACis to increase SSTR2 expression and radiolabeled DOTA-TATE uptake: from cells to mice;Life Sciences;2023-12

5. Promising targetable biomarkers in pancreatic neuroendocrine tumours;Expert Review of Endocrinology & Metabolism;2023-09-03